# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 168


In regulation 212 (amendment of regulation 280 (general principles))—
(a) for “280(1)” substitute “280”;
(b) in paragraph (a)—
(i) at the beginning, insert “in paragraph (1)”;
(ii) for “UK marketing authorisation or” substitute “UK marketing authorisation, EU marketing authorisation,”;
(c) for paragraph (b) substitute—
“(b) after paragraph (1) insert—
“(1A) Where an advertisement mentioned in paragraph (1) relates to a product in relation to which there is a separate authorisation or registration in force in Great Britain and in Northern Ireland, it may not be published in the whole United Kingdom unless it complies with the particulars listed in the summary of the product characteristics in each of those authorisations or registrations (as the case may be).”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/168 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-168
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.